Susan Brown
Hematology & Oncology · Niles, ILNPI 1003805375
Payments from drug & device makers
Across 274 payments — averaging $489.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$101K
- Eli Lilly$21K
- Pfizer$9K
- Amgen$294
- Genentech USA, Inc.$196
- Novartis$181
- plus $2K from 32 others
What the payments were for
- Food & beverage$2,530100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 133 | $101,438 |
| Eli Lilly | 3 | $21,499 |
| Pfizer | 13 | $8,846 |
| Amgen | 13 | $294 |
| Genentech USA, Inc. | 11 | $196 |
| Novartis | 11 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $159 |
| Merck | 9 | $141 |
| E.r. Squibb & Sons, L.L.C. | 11 | $131 |
| Tesaro, Inc. | 3 | $122 |
| Sanofi | 6 | $98 |
| Octapharma USA, Inc. | 1 | $91 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $91 |
| Johnson & Johnson(2 entities) | 5 | $87 |
| Bristol Myers Squibb | 4 | $83 |
| Incyte Corporation | 4 | $73 |
| Astellas Pharma US Inc | 4 | $64 |
| Daiichi Sankyo Inc. | 3 | $62 |
| AbbVie | 3 | $51 |
| Lilly USA, LLC | 3 | $51 |
| Bayer | 3 | $49 |
| AstraZeneca | 3 | $45 |
| Taiho Oncology, Inc. | 2 | $41 |
| EMD Serono, Inc. | 3 | $38 |
| Eisai Inc. | 2 | $32 |
| Array Biopharma Inc | 1 | $23 |
| Exelixis Inc. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Foundation Medicine, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $13 |
| Verastem, Inc. | 1 | $12 |
How this compares
$134,182 in reported general payments places this provider in the 70th percentile of 580 hematology & oncology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Niles
- David HakimianNiles$2.6M
- Leonard KleinNiles$1.9M
- Richard SchilskyBurr Ridge$87.1M
- Edwin PosadasBurr Ridge$70.9M
- Oana DanciuChicago$23.2M
- Shuo MaChicago$20.5M
- Olwen HahnChicago$11.9M
- Christine BestvinaChicago$11.3M
- Russell SzmulewitzChicago$9.8M
- Randy SweisChicago$9.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.